TP53 mutation prevalence in normal airway epithelium as a biomarker for lung cancer risk

BACKGROUND: There is a need for biomarkers that improve accuracy compared with current demographic risk indices to detect individuals at the highest lung cancer risk. Improved risk determination will enable more effective lung cancer screening and better stratification of lung nodules into high or l...

Descripción completa

Detalles Bibliográficos
Autores principales: Craig, Daniel J., Crawford, Erin L., Chen, Heidi, Grogan, Eric L., Deppen, Steven A., Morrison, Thomas, Antic, Sanja L., Massion, Pierre P., Willey, James C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464352/
https://www.ncbi.nlm.nih.gov/pubmed/37612638
http://dx.doi.org/10.1186/s12885-023-11266-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464352/
https://www.ncbi.nlm.nih.gov/pubmed/37612638
http://dx.doi.org/10.1186/s12885-023-11266-7

Ejemplares similares